期刊文献+

原发性十二指肠癌临床特点及其微血管密度检测的意义 被引量:4

Clinical characteristics of primary duodenal carcinoma and meaning of micro-vessel density
下载PDF
导出
摘要 目的分析原发性十二指肠癌的临床特点并探讨微血管生成与其生物学行为及预后的相关性。方法回顾性分析102例原发性十二指肠癌的临床资料并对76例癌标本及癌旁非癌组织行免疫组化S-P法微血管密度(MVD)检测。结果原发性十二指肠癌的高发年龄为40~60岁。黄疸、上腹疼痛、腹胀、消瘦为该组4大主要临床表现。MVD与十二指肠癌的发生、肿瘤大小、组织分化程度、浸润深度、转移、手术切除率及预后均有相关性。结论原发性十二指肠癌具有症状不典型、误诊率高及预后差等特点;CA50、CA19-9联合检测有助诊断;MVD与十二指肠癌生物学行为密切相关且影响预后。 [Objective] To analyze the clinical characteristics and investigate the relationship between microvessel density (MVD) and pathobiological behavior and prognosis in primary duodenal cancer (PDC). [Methods] Chnical data of 102 patients with PDC was analyzed retrospectively. By using SP immunohistochemical method, MVD values in the samples from 76 patients with PDC were measured. [Results] The age of most patients was from 40 to 60 years old. Jaundice, abdominal pain, abdomen bulge and weight loss were common manifestations. MVD was related with PDC,s origin, tumor size, tissue differentiation, invading depth ,metastasis, operation rate and prognosis. [Conclusions] PDC had no characteristic manifestations, had high error diagnosis rate and bad prognosis; Combined determination of CA50 and CA19-9 was useful for the diagnosis; MVD was related to PDC,s biology behavior and affected its prognosis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第15期1887-1889,共3页 China Journal of Modern Medicine
关键词 十二指肠癌 诊断 微血管密度 duodenal carcinoma diagnosis micro-vessel density
  • 相关文献

参考文献2

二级参考文献10

  • 1Mukhopadhy D, Tsikas L, Sukhatme VP, et al. Wild-typep53and v-Src exert opposing influences on human vascular endothelial growth factor gene expression [J]. Cancer Res, 1995, 5:6161-6165.
  • 2Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. Patients: the evidence continues to grow[J]. J Pathol,1998, 184(2): 119-122.
  • 3Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostis hyperplasia[J]. J Urol, 1997, 157(6): 2323-2328.
  • 4Fontanini G, Vignati S, Luchi M, et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and othelial growth factor (VEGF) expression[J]. Br J Cancer, 1997, 75: 1295-1301.
  • 5Machein MR, Risan W, Plate KH. Antiangiogenic gene therapy in a rat gliama model using a dominant-negative vascular 2 [J].Hum Gene Ther, 1999, 10(7): 1117-1128.
  • 6Maeda K, Chung YS, Ogana Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma [J].Cancer, 1996, 77(5): 858-863.
  • 7ZHANG XZ, JIN L, WANG XL, et al. Excessine expression of p53 protein in esopnageal carcinoma and cervical system and it's relationship with actiontherapy sensitirity [J]. Zhongguo Xiadai Yixue Zazhi, 2000, 10(6): 47-48.
  • 8Gary DG, Avid AG, John PS, et al. Thrombospondinl expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression[J]. J Natl Cancer Ins, 1997, 89(3): 219-227.
  • 9Volpert OV, Dameron KM, Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progression to tumorigenicity[J]. Oncogene, 1997, 14(12): 1495-1502.
  • 10Giatromanolaki A, Koukourakis MI, Stathopoulos GP, et al. Angiogentic in interactions of vascular endthelial growth factor othymidine phosphorylase, and of p53 protein expression in local advanced gastric cancer[J]. Oncol Res, 2000, 12(1): 33-41.

共引文献30

同被引文献16

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部